ImmunoTek Bio Centers
Scott Ramsey has extensive work experience in the biotechnology industry. Scott currently holds the position of Executive Vice President/ Chief of Staff at ImmunoTek Bio Centers, LLC since January 2022. Prior to this role, they served as Executive Vice President/ General Manager from March 2021 to February 2022 and as Chief Operating Officer from January 2013 to March 2021 at the same company.
Before joining ImmunoTek Bio Centers, LLC, Scott worked as a Consultant at WSR Consultant from June 2011 to June 2013.
From 2001 to 2010, Scott held various roles at International BioResources, LLC. Scott served as Vice President Unlicensed Operations from May 2008 to July 2010, where they successfully obtained FDA licensure for 33 new plasma collection centers. Scott also served as Director of Operations and Training from November 2006 to May 2008.
Prior to that, Scott held positions of increasing responsibility at International BioResources, LLC from October 2001 to May 2006, including Regional Director & Systems Implementation Specialist and Regional Manager, Regional Quality Manager, Operations Manager. In these roles, they directed operations for multiple plasma donor centers, developed operational initiatives, established accountability points, and prepared reports for the Director.
Scott Ramsey attended JSJC from 1980 to 1984, where they studied Business Administration/Marketing. However, there is no information available regarding the degree they obtained during their time at JSJC.
This person is not in any offices
ImmunoTek Bio Centers
1 followers
ImmunoTek Bio Centers LLC is the world's largest and fastest-growing independent plasma collection center operator. ImmunoTek is a global leader in developing a reliable plasma supply chain for international biotech companies and partnering with organizations for ancillary projects related to blood-plasma collection. Since its inception in 2013, ImmunoTek has built and operated more than 70 plasma collection centers, most of which have achieved or are in the process of attaining U.S. FDA licensure and European certification. ImmunoTek currently has centers operating in 20 states, with 20 additional centers under development and planning underway for more than 40 additional sites over the next three years.